Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide for Low Bone Mass in Anorexia Nervosa
NCT00759772Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Sep 2008
- Primary completion
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in osteoporosis comparing Teriparatide with Placebo (2 arms). Primary endpoint: Percent Change in Lumbar Spine Bone Mineral Density at 6 months. Started Sep 2008; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00759772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00759772.